<DOC>
	<DOCNO>NCT02856477</DOCNO>
	<brief_summary>The study aim assess therapeutic benefit adaptation antidepressant dose metabolic capacity ( cytochrome P450 2D6 ) elderly depressed patient . Therapeutic benefit evaluate enhancement efficiency , decrease action time effect .</brief_summary>
	<brief_title>Pharmacogenetic Antidepressant Treatment Elderly</brief_title>
	<detailed_description />
	<criteria>current major depressive disorder antidepressant treatment dextromethorphan contraindication psychiatric disorder kidney failure liver failure mini mental State Examination ( MMSE ) &lt; 18</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>